ElF4E antibody

Details for Product No. ABIN966057
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Reactivity
Human, Mouse (Murine), Rat (Rattus)
(5), (4), (4)
Host
Rabbit
(5)
Clonality
Polyclonal
Application
Immunohistochemistry (IHC)
(5), (4), (2)
Pubmed 3 references available
Quantity 100 μg
Options
Shipping to United States (Change)
Availability Will be delivered in 5 to 7 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN966057
398.75 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen The antiserum was produced against synthesized non-phosphopeptide derived from human elF4E around the phosphorylation site of serine 209 (S-G-SP-T-T).
Specificity ElF4E (Ab-209) antibody detects endogenous levels of total elF4E protein.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Application Notes WB: 1:500~1:1000
IHC: 1:50~1:100.
Restrictions For Research Use only
Format Liquid
Concentration 100ug/100ul.
Buffer Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Product cited in: Gu, Li, Zhao et al.: "tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes." in: Nucleic acids research, Vol. 32, Issue 15, pp. 4448-61, 2004 (PubMed).

Li, McDonald, Nassar et al.: "Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression." in: Annals of surgery, Vol. 227, Issue 5, pp. 756-6l; discussion 761-3, 1998 (PubMed).

Ohlmann, Rau, Pain et al.: "The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E." in: The EMBO journal, Vol. 15, Issue 6, pp. 1371-82, 1996 (PubMed).

Validation Images
Did you look for something else?
back to top